Partner-Specific HIV Risk Reduction Intervention for Drug-Using Adolescents (GET UP)

This study has been completed.
Sponsor:
Collaborator:
University of Rhode Island
Information provided by (Responsible Party):
Cynthia Rosengard, Women and Infants Hospital of Rhode Island
ClinicalTrials.gov Identifier:
NCT00831883
First received: January 28, 2009
Last updated: December 3, 2012
Last verified: December 2012
  Purpose

The purpose of this study is to develop and pilot test a partner-specific HIV risk reduction intervention for currently or recently incarcerated adolescents who report problematic substance use.


Condition Intervention
Sexually Transmitted Diseases
Substance-Related Disorders
Behavioral: Partner-Specific IMB-based HIV risk reduction intervention
Behavioral: Healthy Lifestyle

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Partner-Specific HIV Risk Reduction Intervention for Drug-Using Incarcerated Adolescents

Resource links provided by NLM:


Further study details as provided by Women and Infants Hospital of Rhode Island:

Primary Outcome Measures:
  • lower levels of sex-related HIV risk behavior [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • knowledge about STI transmission [ Time Frame: 3 months ] [ Designated as safety issue: No ]
  • partner-specific perceptions of STI risks [ Time Frame: 3 months ] [ Designated as safety issue: No ]
  • social norms, expectations and personal attitudes regarding partner-specific sexual behavior [ Time Frame: 3 months ] [ Designated as safety issue: No ]
  • partner-specific behavioral and communication skills [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Enrollment: 59
Study Start Date: February 2009
Study Completion Date: January 2011
Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Partner Specific IMB
partner-specific HIV risk reduction intervention
Behavioral: Partner-Specific IMB-based HIV risk reduction intervention
5 session partner-specific HIV risk reduction group intervention based on the Information-Motivation-Behavioral Skills model.
Placebo Comparator: HLS
5 session psychoeducational group, designed to provide equivalent time and attention, that focuses on the importance of maintaining a good diet, exercise, and developing health skills.
Behavioral: Healthy Lifestyle
5 session psychoeducational group, designed to provide equivalent time and attention, that focuses on the importance of maintaining a good diet, exercise, and developing health skills.

Detailed Description:

Incarcerated adolescents represent a group at high risk for health consequences associated with risky sexual behaviors. Condom use is more common with non-main than main sex partners and substance use in conjunction with sexual risk also appears to vary by partner type. The research team will conduct a small randomized trial to pilot test a partner-specific HIV risk reduction intervention for currently or recently incarcerated adolescents who report problematic substance use. Participants will be randomized to a 5 session HIV risk reduction group intervention based on the Information-Motivation-Behavioral Skills model, or a 5 session healthy lifestyles psychoeducation intervention, and then reassessed 3 months after their access to the general community is reinstated. The main hypothesis is that participants in the HIV risk reduction intervention condition will have lower levels of sex-related HIV risk behavior and of substance use in conjunction with sexual risk, relative to those in a healthy lifestyles psychoeducation intervention.

  Eligibility

Ages Eligible for Study:   15 Years to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • English-speaking ability
  • unprotected vaginal, anal, or oral intercourse at least once in the 6 months prior to incarceration or placement
  • marijuana use disorders, other non-injection drug use disorders, or substance use by a sexual partner during a sexual episode in the six months prior to incarceration or placement
  • sentence or placement length between 2 and 12 months
  • must plan to remain in the area for the 6 months following their release from the facility
  • must be willing to provide two pieces of contact information for follow-up

Exclusion Criteria:

  • signs of psychosis (assessed through clinical assessment)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00831883

Locations
United States, Rhode Island
Women & Infants Hospital of Rhode Island
Providence, Rhode Island, United States, 02905
Sponsors and Collaborators
Women and Infants Hospital of Rhode Island
University of Rhode Island
Investigators
Principal Investigator: Cynthia Rosengard, PhD, MPH Women & Infants of Rhode Island
  More Information

No publications provided

Responsible Party: Cynthia Rosengard, Cynthia Rosengard, Ph.D., Women and Infants Hospital of Rhode Island
ClinicalTrials.gov Identifier: NCT00831883     History of Changes
Other Study ID Numbers: 08-0128, R01 DA022921-03
Study First Received: January 28, 2009
Last Updated: December 3, 2012
Health Authority: United States: Institutional Review Board
United States: Federal Government

Keywords provided by Women and Infants Hospital of Rhode Island:
Adolescent
Adolescent behavior
Health behavior
Sexual Behavior
Incarceration
Behavioral Intervention
Risk Reduction Behavior

Additional relevant MeSH terms:
Sexually Transmitted Diseases
Substance-Related Disorders
Infection
Virus Diseases
Genital Diseases, Male
Genital Diseases, Female
Chemically-Induced Disorders
Mental Disorders

ClinicalTrials.gov processed this record on July 31, 2014